Pasithea Therapeutics Corp. (KTTA)
Nasdaq: KTTA · Pharmaceutical Preparations · Miami Beach, FL · filing with the SEC since 2021
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 30, 2026 | Mar 24, 2025 | Mar 29, 2024 | Mar 30, 2023 | Mar 30, 2022 |
| Revenue | · | · | · | 486,559 | 15,062 |
| For lenders | |||||
| Net interest income | · | · | · | · | -508 |
| Cost of revenue | · | · | · | 113,195 | 17,275 |
| Gross profit | · | · | · | · | -2,213 |
| Research and development | 7,981,120 | 7,198,494 | 8,100,765 | 2,665,427 | · |
| Selling, general and administrative | · | 7,051,468 | 7,878,596 | 9,923,544r | 4,505,200 |
| General and administrative | 12,876,175 | 7,051,468 | · | · | · |
| Total costs and expenses | · | · | · | 697,121 | · |
| Operating income | -20,857,295 | -14,249,962 | -15,979,361 | -12,588,971r | -4,507,413 |
| Interest expense | · | · | · | 102 | 508 |
| Interest and investment income | 327,193 | 423,184 | 415,368 | · | · |
| Other income (expense), net | 7,000 | · | 471,613 | 861,086 | · |
| Total non-operating income (expense) | 429,612 | 345,378 | 471,613 | · | 2,333,892 |
| Income before income taxes | -20,427,683 | -13,904,584 | -15,507,748 | -11,727,885r | -2,173,521 |
| Income from continuing operations | · | -13,904,584 | -15,507,748 | -11,727,885 | · |
| Income from discontinued operations | · | · | -453,910 | -2,208,567 | · |
| Net income including non-controlling interests | · | · | · | · | -2,173,521 |
| Net income | -20,427,683 | -13,904,584 | -15,961,658 | -13,936,452 | -2,173,521 |
| Earnings per share, basic | -2.91 | -12.69 | -0.42 | -1.76r | -0.21 |
| Earnings per share, diluted | -2.91 | -12.69 | -0.42 | -1.76r | -0.21 |
| Weighted average shares, basic | 7,031,050 | 1,096,082 | 1,226,600 | 1,262,339r | 10,404,668 |
| Weighted average shares, diluted | 7,031,050 | 1,096,082 | 1,226,600 | 1,262,339r | 10,404,668 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestAndDividendOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding